B.O.S.S. Retirement Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-37,457
Closed -$3.11M 250
2023
Q1
$3.11M Buy
37,457
+1,918
+5% +$159K 0.73% 30
2022
Q4
$3.05M Buy
+35,539
New +$2.81M 0.78% 26

Other funds holding GILD

B.O.S.S. Retirement Advisors's GILD Position: Q2 2023 in Review

B.O.S.S. Retirement Advisors sold out of Gilead Sciences (GILD) in Q2 2023, closing a stake of 37,457 shares — an estimated $3.11M sold.

B.O.S.S. Retirement Advisors first reported a position in GILD in Q4 2022 and held it in 2 quarters. The position peaked at $3.11M in Q1 2023. 1,701 funds tracked by Wall St. Rank hold GILD as of Q2 2023.

  • B.O.S.S. Retirement Advisors reported no remaining Gilead Sciences position as of Q2 2023 after selling out during the quarter.
  • B.O.S.S. Retirement Advisors sold 37,457 Gilead Sciences shares in Q2 2023, an estimated $3.11M.
  • B.O.S.S. Retirement Advisors first reported a position in Gilead Sciences in Q4 2022 and held it in 2 quarters.
  • B.O.S.S. Retirement Advisors's Gilead Sciences position peaked at $3.11M in Q1 2023.
  • 1,701 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2023.

Based on B.O.S.S. Retirement Advisors's 13F filing for Q2 2023, filed 10 Jul 2023.